CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC75870

Market Closed - Boerse Frankfurt Warrants 20:40:20 17/05/2024 BST
132.1 EUR +0.08% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-0.23%
1 month+3.61%
Date Price Change
17/05/24 132 +0.02%
16/05/24 132 +0.04%
15/05/24 132 +0.75%
14/05/24 131 -0.40%
13/05/24 131.5 -0.88%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 08:40 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC7587
ISINDE000PC75870
Date issued 11/04/2024
Strike 150 $
Maturity 20/09/2024 (124 Days)
Parity 1 : 1
Emission price 124.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 133
Lowest since issue 126.4
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus